Home About Us Services ↳ Canada PR Visa (Permanent Residency) ↳ Work Permit Canada ↳ LMIA — Labour Market Impact Assessment ↳ Spouse & Family Sponsorship Visa ↳ Student Visa Canada ↳ Visitor Visa ↳ Business Visa Provinces ↳ 🏙️ Ontario ↳ 🏔️ British Columbia ↳ 🌾 Alberta ↳ 🌻 Saskatchewan ↳ 🌊 Manitoba ↳ ⚓ Nova Scotia ↳ 🍁 New Brunswick ↳ 🦞 Prince Edward Island ↳ 🐟 Newfoundland & Labrador ↳ 🌊 Atlantic Immigration Program Healthcare Blog FAQ Careers Canadian Latest policies Contact

Guidance on efficacy requirements for biocides: Preparing your benefits package

On this page

Summary of benefits information

Certain applications must contain a summary of the information included in your application about the benefits and any related uncertainties of your biocide. Find information on when an efficacy summary is required and what should be included in the efficacy summary.

Do not include detailed information on efficacy data reporting in your summary.

The efficacy summary should include a summary of the efficacy reports submitted in support of the benefits of your biocide.

Organisms used

You should include the following information for the test organisms you used in each efficacy study:

  • name
  • source (stock supplier)
    • for example, the American Type Culture Collection (ATCC) identifier and the American Society of Testing and Materials (ASTM) identifier
  • identity of the specific strain, if applicable

You should also specify the purpose of the study, such as:

  • adding a claim or
  • confirmatory data and the changed condition that prompted confirmatory testing (refer to summary table below for an example)

Test product

For each efficacy study, describe the test product formulation used in each batch test, including :

  • name of the test product
  • application method used in testing
    • for example, immersion, spray, towelettes
  • ready-to-use (RTU) product or dilution used (for biocides that are diluted from a concentrated formulation) and its definition in testing
    • for example, 1:256 (1 part product in 256 parts water)
  • tested contact time

If you are referencing efficacy data from another biocide to support a claim, refer to the example summary template for how to indicate this.

Batches and carriers

For each efficacy study, indicate:

  • the number of batches used
  • the number of carriers used per batch
  • the type of carrier used
    • for example, steel disk, cotton and polyester swatches

Organic burden level (soil load)

For each efficacy study, indicate:

  • the specific burden load
    • for example, 5% fetal bovine serum (FBS) or no soil load

Test method

For each efficacy study, indicate the:

  • name of the current test method (with additional information about modifications, if any)
    • for example, ASTM 961.02 (modified for mycobacteria)

Performance criteria (results)

For each efficacy study, as per prescribed test method used, indicate the:

  • quantitative or qualitative results for each batch
    • for example, greater than or equal to 3 log10 reduction in viral titer beyond the cytotoxic level for all the test carriers or 59/60 carriers negative for growth, as appropriate

Laboratory report identifier

For each efficacy study, indicate the:

  • unique identification number of your efficacy report
    • for example:
      • 506-259 (Laboratory Project Identification Number) or
      • 506-259 (Project Number) or
      • 2304884-404 (Laboratory Study Number)

Other information

If it applies, you should also provide:

  • post-meeting notes of pre-submission meetings or discussions
  • any correspondence related to your submission (for example, emails)
  • reason(s) for submitting new efficacy data
    • for previously approved claims against specific micro-organisms
  • your biocide's regulatory status in foreign jurisdictions and any differences in its efficacy profile

Example of a summary template for efficacy data

To summarize your efficacy data for a biocide, use:

  • the following template or
  • a different format that contains the same information

The summary should outline the:

  • new or revised (in the case of a post-authorization change) claims for your biocide for each microbial category and
  • data to support the claims
Summary Table Example (for efficacy data)
Efficacy testing: Parameters and other information to support label claims
Purpose of the study and organism Test product name, application method, RTU or dilution, and contact time

Or

Cross-referenced identification number of biocide

Number of batches and carriers, carrier type Soil load Test method Reported performance criteria Report identifier
Hard surface disinfection claims
Bacteria
Addition of general (broad-spectrum) and specific claims against Staphylococcus aureus (ATCC 6538) "Test product name", Immersion, 1:256 (1 part product in 256 parts water), 5 minutes

3 batches

60 carriers/batch, steel disk

5% FBS AOAC 955.15

Batch #1: 59/60 negative for growth

Batch #2: 60/60 negative for growth

Batch #3: 58/60 negative for growth

A38573
Addition of general (broad-spectrum) and specific claims against Pseudomonas aeruginosa (ATCC 15442) "Test product name", Immersion, 1:256 (1 part product in 256 parts water), 5 minutes

3 batches

60 carriers/batch, steel disk

5% FBS AOAC 964.02

Batch #1: 54/60 negative for growth

Batch #2: 56/60 negative for growth

Batch #3: 55/60 negative for growth

A38574

Confirmatory data to reduce contact time to 4 minutes for hard-surface disinfection claims against all bacteria

Staphylococcus aureus (ATCC 6538)

"Test product name", Immersion, 1:256 (1 part product in 256 parts water), 3 minutes and 54 seconds

2 batches

10 carriers/batch, steel disk

5% FBS AOAC 955.15 10/10 carrier negative for growth per batch A32450

Confirmatory data to reduce contact time to 4 minutes for hard-surface disinfection claims against all bacteria

Pseudomonas aeruginosa (ATCC 15442)

"Test product name", Immersion, 1:256 (1 part product in 256 parts water), 3 minutes and 54 seconds

2 batches

10 carriers/batch, steel disk

5% FBS AOAC 964.02 10/10 carrier negative for growth per batch A32451
Addition of claim against Campylobacter jejuni (ATCC 29428) "Test product name", Immersion, 1:256 (1 part product in 256 parts water), 3 minutes and 54 seconds

2 batches

10 carriers/batch, steel disk

5% FBS AOAC Use-Dilution Method 10/10 carrier negative for growth per batch A38547
Addition of a claim against Klebsiella pneumoniae (ATCC 4352) Reference biocide identification number
Viruses
Addition of a claim against Rhinovirus type 37 (ATCC VR-1607), Strain 151-1 "Test product name", RTU spray

2 batches

carrier/batch

No soil load ASTM E1053 3.25 log10  reduction in viral titer per carrier beyond the cytotoxic level for all the test carriers A38647

Abbreviation:

AOAC: Association of Official Analytical Collaboration

ASTM: American Society of Testing and Materials

FBS: Fetal Bovine Serum

Data may be referenced from an existing authorized biocide if:

  • your biocide has the same formulation or is very similar in formulation
  • the data are owned by the same company or can be accessed through a letter of authorization

Page details

2025-08-13

Quick Enquiry

We usually reply within a few hours
By submitting you agree to be contacted about your enquiry.
Call us Chat on WhatsApp
M

Migova AI Assistant

Online now
Hi 👋 I'm the Migova AI assistant, powered by OpenAI. Ask me about PR, study visas, work permits, LMIA, family sponsorship, provinces, or healthcare immigration to Canada.
Canada PR
Study Visa
LMIA / Work Permit